Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
暂无分享,去创建一个
N. Reinmuth | Ying Cheng | A. Mansfield | M. Nishio | M. Mccleland | A. Scherpereel | J. de Castro Carpeno | M. Reck | M. Garassino | L. Horn | Stephen V. Liu | R. Califano | S. Phan | T. Leal | F. Orlandi | Yu Deng | J. Alatorre-Alexander | T. Mok | Jong-Seok Lee | S. Lam | Y. Deng | J. de Castro Carpeño | M. McCleland | J. Alatorre-Alexander | Yu Deng